Krishnendu “Krish” Roy, biomedical engineering professor and founding director of the NSF Engineering Research Center for Cell Manufacturing Technologies (CMaT), is leaving Georgia Tech to accept a leadership post at Vanderbilt University.
In a news story published today, Vanderbilt announced it has hired Roy as its next Bruce and Bridgitt Evans Dean of Engineering.
“It is hard to part ways with the place and people you love,” said Roy, Regents’ Professor and Robert A. Milton Endowed Chair in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.
“I am excited about the incredible opportunities at Vanderbilt, but at the same time, sad to leave my Georgia Tech and CMaT family behind,” Roy added. “I am profoundly grateful for all the support I have received over the years from the administrators, faculty, staff, and students at Georgia Tech.”
A pioneer in the field of immunoengineering – particularly in the development and use of biomaterials and cellular engineering tools to solve biomedical problems – Roy came to Georgia Tech in 2013 from the University of Texas-Austin. He’ll begin his new role at Vanderbilt on August 1.
Roy also is director of the Marcus Center for Cell Characterization and Manufacturing (MC3M), Center for Immunoengineering, and a researcher in two interdisciplinary research institutes at Georgia Tech – the Petit Institute for Bioengineering and Bioscience (IBB), and the Institute for Electronics and Nanotechnology (IEN).
Latest BME News
The 2007 BME alum will lead efforts to bring medical technologies to market.
BME graduate leveraging Coulter experience to bridge continents and inspire students
Seven other Faculty Members from Coulter Department Named to Fall 2024 Honor Roll
Researcher Michaël Girard delivers eye-popping presentation at BME Seminar Series
Anant Madabhushi part of Emory team awarded up to $17.6 million to innovate surgery, improve outcomes
BME researchers combine precision and simplicity in transforming diagnostic tools.
Researchers demonstrate stem cell treatment without chemotherapy and painful bone marrow procedure
BME researchers explore the critical role of mechanical force in rare genetic disorder